Physical activity protects against chronic diseases. Preclinical studies suggest that circulating levels of the myokine β-amino-isobutyric acid (BAIBA) may prevent obesity and improve cardiometabolic health.
OBJECTIVE:
To assess whether serum BAIBA is associated with physical activity, markers of cardiometabolic risk, and gender differences among young individuals.
METHODS:
A cross-sectional study was conducted on 80 university students. Anthropometry, blood pressure, lipid profile, fasting blood glucose (FBS), C-reactive protein, cortisol and physical activity (PA) were measured and analyzed against serum BAIBA levels.
RESULTS:
Average BAIBA levels were 1.57±0.61 μM. Males had significantly larger waist (86.0±9.6 cm) and neck circumferences (38.6±2.5 cm), systolic and diastolic blood pressure (124.9±11.7 mmHg and 77.9±9.9 mmHg, respectively), FBS (84.6±7.5 mg/dL), cortisol (594.8±158.9 nmol/L) and PA levels than females. They also had significantly lower high-density lipoprotein (46.9±7.3 mg/dL). BAIBA concentrations in males and females were not significantly different. No significant association was found between BAIBA concentrations and nutritional, metabolic and functional parameters, except for diastolic blood pressure (DBP) in males (r = –0.35; p = 0.03).
CONCLUSIONS:
In healthy, young individuals, serum BAIBA levels were not related to nutritional status, metabolic status, and physical activity, but were inversely related to DBP in males only.
Get full access to this article
View all access options for this article.
References
1.
MurrayCJ, BarberRM, ForemanKJ, Abbasoglu OzgorenA, Abd-AllahF, AberaSF, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition. Lancet(London England). 2015;386(10009):2145–91.
2.
NgM, FlemingT, RobinsonM, ThomsonB, GraetzN, MargonoC, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet (London England). 2014;384(9945):766–81.
3.
FinucaneMM, StevensGA, CowanMJ, DanaeiG, LinJK, PaciorekCJ, et al. National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet (London, England). 2011;377(9765):557–67.
4.
ForouzanfarMH, AlexanderL, AndersonHR, BachmanVF, BiryukovS, BrauerM, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet (London England). 2015;386(10010):2287–323.
5.
VisscherTL, SeidellJC. The public health impact of obesity. Annu Rev Public Health. 2001;22:355–75.
6.
TaylorVH, ForhanM, VigodSN, McIntyreRS, MorrisonKM. The impact of obesity on quality of life. Best Pract Res Clin Endocrinol Metab. 2013;27(2):139–46.
7.
BlackstoneRP. Obesity: The medical practitioner’s essential guide. New York: Springer Scientific; 2016.
8.
LehnertT, SonntagD, KonnopkaA, Riedel-HellerS, KonigHH. Economic costs of overweight and obesity. Best Pract Res Clin Endocrinol Metab. 2013;27(2):105–15.
9.
BostromP, WuJ, JedrychowskiMP, KordeA, YeL, LoJC, et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–8.
10.
RobertsLD, BostromP, O’SullivanJF, SchinzelRT, LewisGD, DejamA, et al. beta-Aminoisobutyric acid induces browning of white fat and hepatic beta-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab. 2014;19(1):96–108.
11.
JungTW, HwangHJ, HongHC, YooHJ, BaikSH, ChoiKM. BAIBA attenuates insulin resistance and inflammation induced by palmitate or a high fat diet via an AMPK-PPARdelta-dependent pathway in mice. Diabetologia. 2015;58(9):2096–105.
12.
ZeidanRK, FarahR, ChahineMN, AsmarR, HosseiniH, SalamehP, et al. Prevalence and correlates of coronary heart disease: First population-based study in Lebanon. Vasc Health Risk Manag. 2016;12:75–84.
13.
PickeringTG, HallJE, AppelLJ, FalknerBE, GravesJ, HillMN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111(5):697–716.
14.
WheltonPK, CareyRM, AronowWS, CaseyDE, CollinsKJ, Dennison HimmelfarbC, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127.
15.
van der KooyK, SeidellJC. Techniques for the measurement of visceral fat: A practical guide. Int J Obes Relat Metab Disord. 1993;17(4):187–96.
16.
AswathappaJ, GargS, KuttyK, ShankarV. Neck circumference as an anthropometric measure of obesity in diabetics. N Am J Med Sci. 2013;5(1):28–31.
17.
CraigCL, MarshallAL, SjostromM, BaumanAE, BoothML, AinsworthBE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.
18.
World Health Organization Report of WHO consultation on obesity. Obesity: Preventing and managing the global epidemic. Geneva. World Health Organization. 2000;894:i–xii, 1-253.
19.
NathanDM, DavidsonMB, DeFronzoRA, HeineRJ, HenryRR, PratleyR, et al. Impaired Fasting Glucose and Impaired Glucose Tolerance. Implications for Care. 2007;30(3):753–9.
20.
AlbertiKG, EckelRH, GrundySM, ZimmetPZ, CleemanJI, DonatoKA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.
21.
SibaiA-M, ObeidO, BatalM, AdraN, KhouryDE, HwallaN. Prevalence and correlates of metabolic syndrome in an adult Lebanese population. CVD Prevention and Control. 2008;3(2):83–90.
22.
GaudreaultV, DespresJP, RheaumeC, BergeronJ, AlmerasN, TremblayA, et al. Exercise-induced exaggerated blood pressure response in men with the metabolic syndrome: The role of the autonomous nervous system. Blood Press Monit. 2013;18(5):252–8.
23.
MoralesFE, ForsseJS, AndreTL, McKinley-BarnardSK, HwangPS, AnthonyIG, et al. BAIBA Does Not Regulate UCP-3 Expression in Human Skeletal Muscle as a Response to Aerobic Exercise. J Am Coll Nutr. 2017;36(3):200–9.
24.
RietmanA, StanleyTL, ClishC, MoothaV, MensinkM, GrinspoonSK, et al. Associations between plasma branched-chain amino acids, beta-aminoisobutyric acid and body composition. J Nut Sci. 2016;5:e6.
25.
MolfinoA, AmabileMI, AmmannT, FarcomeniA, LionettoL, SimmacoM, et al. The metabolite beta-aminoisobutyric acid and physical inactivity among hemodialysis patients. Nutrition. 2017;34:101–7.
National High Blood Pressure Education P. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2004.
